Determination of Maromolecular Structures Using Synchrotron Radiation for the Eluc...
Crystal Structure and Biochemical Characterization of the Recombinant ThBgl, a GH1...
Structural studies for drug discovery against human infectious diseases
![]() | |
Author(s): |
Frederico Moraes Ferreira
Total Authors: 1
|
Document type: | Doctoral Thesis |
Press: | São Carlos. |
Institution: | Universidade de São Paulo (USP). Instituto de Física de São Carlos (IFSC/BT) |
Defense date: | 2004-10-23 |
Examining board members: |
Glaucius Oliva;
Raghuvir Krishnaswamy Arni;
Maria Cristina Nonato Costa;
Javier Alcides Ellena;
Jorge Iulek
|
Advisor: | Glaucius Oliva |
Abstract | |
The goal of the present work is to elucidate the crystallographic structure of the protein N-acetylglucosamine Bphosphate deacetylase (deacetylase) from Escherichia coli. The deacetylase is a tetramer of identical subunits with 382 aminoacids and molecular weight of 41 kDa. It is an euzyme of the amino sugar catabolism pathway and it catalyzes the conversion of the N-acetylglucosamine Gphosphate in to glucosamine 6-phosphate. In this pathway the bacteria dedicates five genes organized in the nagE-nagBACD regulon for purposes of cell wall component recycling and energy production. The cell wall component recycling is the major E. coli metabolic pathway in which aproximately 40% of the cellular wall peptidoglicans is broken in each generation. Its degradation product, the amino sugar N-acetylglucosamine (GlcNAC) is reused for the peptidoglican and for the lipopolysacharide de novo synthesis. The GlcNAC plays several regulatory roles in the amino sugar catabolism pathway and deacetylase is its major intra cellular concentration controlling factos. It was demonstrated that without the deacetylase, E. coli is uncapable of recycling the GlcNAc. The deacetylase plays important roles in the other organisms in which it has been found. It is related to the carbohydrate up-take and storage in hepatocytes and sinusoidal cells from rat liver and to the Candida albicans morphogenesis, pathogenicity and adherence to the endothelial tissues. Deacetylase has also been studied in the development of inhibitors against the malaria parasite Plasmodzum falciparum. This work describes all the approaches from the nagA subcloning to the crystallographic structure analysis, including deacetylase expression, purification, crystallization, heavy atoms derivatives production, phasing, model building and model refinement. The E. coli deacetylase structure was solved by Single Anomalous Dispersion using low resolution (2,0 angstron) iodine anomalous scattering. The structure was refined to 2,0 angstron resolution. The contends of the asymmetric unit is a dimer related by a non-crystallographic 2-fold symmetry axis about 15° from the crystallographic axis c. The crystallographic symmetry applied to the asymmetric unit produces a tetramer, whose the surface accessibility of the buried area is 5.343 angstron, corresponding to 18.4 % of the dimer total area. The dimer surface accessibility of the buried area is 1.053 angstron2, corresponding to 6.8 % of the monomer total area. The deacetylase monomer folds into two domains, a pseudo (beta/alfa)8 barrel enclosing the catalytic site of the enzyme and a small beta sandwich made up from secondary structure elements contributed by the N and C termini. The beta domain is composed of two mixt beta sheets and one alfa helice. The alfa domain is composed of 11 alfa helices and 3 beta sheets, one of them parallel and the other two anti parallel. In the alfa domain, 8 alfa helices are cross linked to 8 beta strands to form the pseudo barrel which encloses the active site. A phosphate ion was found into the catalytic site. The catalytic residues that bind the phosphate ion are Gln59, Glu131, Hisl95, His216 and Asp273, from which at least one histidine and one aspartic acid are conserved amongst the Amidrohydrolases super family members (AU) |